Join WMDA for an informative webinar on the latest changes in HLA nomenclature and their implications for patient matching, donor selection, and search results.
This session will provide specific information about the reclassification of the C*04:09N allele from a null to a low-expression allele (C*04:09L), which may influence HCT matching strategies. Kim Wadsworth and Valerie Stewart (NMDP) will discuss what this means for clinical practice and how to adapt to these changes moving forward.
Don’t miss this opportunity to stay informed and ensure best practices in donor selection and patient care. Register today!